For the last while, The Green Organic Dutchman (TSX:TGOD) (OTCQX:TGODF) has been working alongside Caliper Foods, conducting a preliminary human PK study on Caliper CBD. Today, we have received the results of this study—and everything’s looking positive. On the news, however, TGOD stock has moved into the red, currently trading down around 2%.
Here’s everything we know.
TGOD Stock Unphased By Preliminary Study Results
On Monday, September 9, TGOD said its PK study, which looked at Caliper CBD, Caliper Foods’ tasteless and odorless water-soluble powder that can be added to food and beverages, received positives results. For instance, the study found that consumers absorbed more CBD with Caliper CBD than with CBD that is in MCT oil. “This study confirms that consumers absorb 4.5 times more CBD with Caliper CBD than with CBD in MCT oil,” said Keith Woelfel of Caliper Foods.
This preliminary study is all part of The Green Organic Dutchman’s plan to commercialize organic cannabinoid dissolves. The Toronto-based cannabis company plans to do so in its native country starting in December 2019. “We are thrilled with the results of this preliminary PK study which demonstrate the consistency and precision of Caliper Foods’ proven proprietary technology which is already available in Colorado and which TGOD will commercialize in Canada,” said Dr. Rav Kumar, CSO of The Green Organic Dutchman.
More is to come from TGOD and Caliper Foods. According to the press release, now that the two companies have conducted a promising initial study, they will soon carry out a confirmatory Clinical Phase 1A PK study. But the market doesn’t seem as impressed as one might have thought.
At the time of writing, TGOD stock is trading at $2.92 on the Toronto Stock Exchange, putting TGOD stock down 2.17%.
Do you have any thoughts on the latest TGOD announcement? Based on the results, would you have thought that TGOD stock would have traded in the green Monday? Let us know your thoughts in the comments below.
Featured image: Canva